IL148813A0 - Method for administering a phosphodiesterase 4 inhibitor - Google Patents
Method for administering a phosphodiesterase 4 inhibitorInfo
- Publication number
- IL148813A0 IL148813A0 IL14881300A IL14881300A IL148813A0 IL 148813 A0 IL148813 A0 IL 148813A0 IL 14881300 A IL14881300 A IL 14881300A IL 14881300 A IL14881300 A IL 14881300A IL 148813 A0 IL148813 A0 IL 148813A0
- Authority
- IL
- Israel
- Prior art keywords
- phosphodiesterase
- administering
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16247799P | 1999-10-29 | 1999-10-29 | |
| US16264199P | 1999-11-01 | 1999-11-01 | |
| US17981700P | 2000-02-02 | 2000-02-02 | |
| PCT/US2000/029453 WO2001032165A1 (en) | 1999-10-29 | 2000-10-26 | Method for administering a phosphodiesterase 4 inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL148813A0 true IL148813A0 (en) | 2002-09-12 |
Family
ID=27388757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14881300A IL148813A0 (en) | 1999-10-29 | 2000-10-26 | Method for administering a phosphodiesterase 4 inhibitor |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20030212112A1 (no) |
| EP (1) | EP1225884A4 (no) |
| JP (1) | JP2003513038A (no) |
| KR (1) | KR20020050249A (no) |
| CN (1) | CN1387433A (no) |
| AP (1) | AP2002002446A0 (no) |
| AR (1) | AR026254A1 (no) |
| AU (1) | AU772909B2 (no) |
| BG (1) | BG106623A (no) |
| BR (1) | BR0015039A (no) |
| CA (1) | CA2389293A1 (no) |
| CO (1) | CO5271676A1 (no) |
| CZ (1) | CZ20021443A3 (no) |
| DZ (1) | DZ3249A1 (no) |
| EA (1) | EA200200502A1 (no) |
| HK (1) | HK1049105A1 (no) |
| HU (1) | HUP0203682A3 (no) |
| IL (1) | IL148813A0 (no) |
| MA (1) | MA25562A1 (no) |
| MX (1) | MXPA02004220A (no) |
| NO (1) | NO20021937L (no) |
| NZ (1) | NZ518002A (no) |
| OA (1) | OA12078A (no) |
| PE (1) | PE20011004A1 (no) |
| PL (1) | PL355262A1 (no) |
| SK (1) | SK7292002A3 (no) |
| TR (1) | TR200201150T2 (no) |
| UY (1) | UY26422A1 (no) |
| WO (1) | WO2001032165A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR029984A1 (es) * | 2000-07-27 | 2003-07-23 | Smithkline Beecham Corp | Metodo para reducir las exacerbaciones asociadas copd ambito |
| DE10207160A1 (de) * | 2002-02-20 | 2003-12-18 | Altana Pharma Ag | Darreichungsform enthaltend PDE 4-Hemmer als Wirkstoff |
| MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| ATE417628T1 (de) * | 2002-05-28 | 2009-01-15 | Nycomed Gmbh | Topisch anwendbare pharmazeutische zubereitung |
| US6822114B1 (en) | 2002-10-08 | 2004-11-23 | Albemarle Corporation | Process for production of fluoroalkoxy-substituted benzamides and their intermediates |
| ME00524B (me) | 2003-03-10 | 2011-10-10 | Astrazeneca Ab | Novi postupak za dobijanje roflumilasta |
| US20060239927A1 (en) * | 2003-03-31 | 2006-10-26 | Kyowa Hakko Kogyo Co., | Drug for airway administration |
| US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| CA2601250C (en) | 2005-03-16 | 2014-10-28 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
| RU2576033C2 (ru) * | 2009-12-03 | 2016-02-27 | Опко Хелс, Инк. | Составы на основе гиперсулфатированных дисахаридов |
| KR102035362B1 (ko) * | 2011-12-27 | 2019-10-22 | 셀진 코포레이션 | (+)-2-[1-(3-에톡시-4-메톡시-페닐)-2-메탄술포닐-에틸]-4-아세틸아미노이소인돌린-1,3-디온의 제제 |
| CN103536582A (zh) * | 2013-10-12 | 2014-01-29 | 云南龙海天然植物药业有限公司 | 罗氟司特干粉吸入剂 |
| US20210031012A1 (en) | 2018-01-26 | 2021-02-04 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
| KR20210095165A (ko) | 2018-11-19 | 2021-07-30 | 프로제너티, 인크. | 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스 |
| CN115666704A (zh) | 2019-12-13 | 2023-01-31 | 比奥拉治疗股份有限公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684516A (en) * | 1983-08-01 | 1987-08-04 | Alra Laboratories, Inc. | Sustained release tablets and method of making same |
| MY121142A (en) * | 1999-02-23 | 2005-12-30 | Smithkline Beecham Corp | Controlled release formulation for treating copd |
| AR035987A1 (es) * | 1999-03-01 | 2004-08-04 | Smithkline Beecham Corp | Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio |
-
2000
- 2000-10-26 NZ NZ518002A patent/NZ518002A/en unknown
- 2000-10-26 DZ DZ003249A patent/DZ3249A1/fr active
- 2000-10-26 HU HU0203682A patent/HUP0203682A3/hu unknown
- 2000-10-26 CA CA002389293A patent/CA2389293A1/en not_active Abandoned
- 2000-10-26 AU AU13445/01A patent/AU772909B2/en not_active Ceased
- 2000-10-26 EA EA200200502A patent/EA200200502A1/ru unknown
- 2000-10-26 AP APAP/P/2002/002446A patent/AP2002002446A0/en unknown
- 2000-10-26 CN CN00815150A patent/CN1387433A/zh active Pending
- 2000-10-26 AR ARP000105644A patent/AR026254A1/es not_active Application Discontinuation
- 2000-10-26 CZ CZ20021443A patent/CZ20021443A3/cs unknown
- 2000-10-26 CO CO00081570A patent/CO5271676A1/es not_active Application Discontinuation
- 2000-10-26 SK SK729-2002A patent/SK7292002A3/sk unknown
- 2000-10-26 OA OA1200200126A patent/OA12078A/en unknown
- 2000-10-26 TR TR2002/01150T patent/TR200201150T2/xx unknown
- 2000-10-26 EP EP00975385A patent/EP1225884A4/en not_active Withdrawn
- 2000-10-26 PL PL00355262A patent/PL355262A1/xx unknown
- 2000-10-26 IL IL14881300A patent/IL148813A0/xx unknown
- 2000-10-26 JP JP2001534370A patent/JP2003513038A/ja not_active Withdrawn
- 2000-10-26 KR KR1020027005448A patent/KR20020050249A/ko not_active Application Discontinuation
- 2000-10-26 MX MXPA02004220A patent/MXPA02004220A/es unknown
- 2000-10-26 BR BR0015039-8A patent/BR0015039A/pt not_active IP Right Cessation
- 2000-10-26 WO PCT/US2000/029453 patent/WO2001032165A1/en not_active Application Discontinuation
- 2000-10-27 PE PE2000001157A patent/PE20011004A1/es not_active Application Discontinuation
- 2000-10-30 UY UY26422A patent/UY26422A1/es not_active Application Discontinuation
-
2002
- 2002-04-17 BG BG106623A patent/BG106623A/bg unknown
- 2002-04-24 NO NO20021937A patent/NO20021937L/no not_active Application Discontinuation
- 2002-04-26 MA MA26618A patent/MA25562A1/fr unknown
- 2002-12-19 HK HK02109231.8A patent/HK1049105A1/zh unknown
-
2003
- 2003-05-02 US US10/429,666 patent/US20030212112A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU1344501A (en) | 2001-05-14 |
| UY26422A1 (es) | 2001-07-31 |
| BR0015039A (pt) | 2002-06-25 |
| JP2003513038A (ja) | 2003-04-08 |
| AR026254A1 (es) | 2003-02-05 |
| NZ518002A (en) | 2004-01-30 |
| TR200201150T2 (tr) | 2002-09-23 |
| CN1387433A (zh) | 2002-12-25 |
| PE20011004A1 (es) | 2001-09-28 |
| KR20020050249A (ko) | 2002-06-26 |
| DZ3249A1 (fr) | 2001-05-10 |
| CA2389293A1 (en) | 2001-05-10 |
| OA12078A (en) | 2003-05-28 |
| MA25562A1 (fr) | 2002-10-01 |
| SK7292002A3 (en) | 2002-12-03 |
| CO5271676A1 (es) | 2003-04-30 |
| MXPA02004220A (es) | 2002-10-17 |
| WO2001032165A1 (en) | 2001-05-10 |
| EP1225884A4 (en) | 2005-06-15 |
| HK1049105A1 (zh) | 2003-05-02 |
| AP2002002446A0 (en) | 2002-03-31 |
| US20030212112A1 (en) | 2003-11-13 |
| CZ20021443A3 (cs) | 2003-01-15 |
| PL355262A1 (en) | 2004-04-05 |
| EP1225884A1 (en) | 2002-07-31 |
| HUP0203682A2 (hu) | 2003-04-28 |
| NO20021937L (no) | 2002-05-30 |
| BG106623A (bg) | 2003-02-28 |
| AU772909B2 (en) | 2004-05-13 |
| NO20021937D0 (no) | 2002-04-24 |
| EA200200502A1 (ru) | 2002-10-31 |
| HUP0203682A3 (en) | 2003-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL141445A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| EG23979A (en) | Renin inhibitors | |
| GB9900416D0 (en) | Inhibitors | |
| GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
| PL362903A1 (en) | Renin inhibitors | |
| IL148813A0 (en) | Method for administering a phosphodiesterase 4 inhibitor | |
| AU2274299A (en) | Benzazine derivatives phosphodiesterase 4 inhibitors | |
| HK1039124B (zh) | 二氮雜萘衍生物磷酸二酯酶4抑制劑 | |
| HUP0000536A2 (en) | Method for levelling a track | |
| IL141446A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| EP1237112A4 (en) | METHOD OF MAKING SECURE TRANSACTIONS ON ELECTRONIC BANKING BOOK (TIRELIRE) | |
| MY133515A (en) | Shim removing tool | |
| EP1153022A4 (en) | PROTEASE INHIBITORS | |
| GB9925659D0 (en) | A method of verification | |
| HUP0200455A3 (en) | Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6) | |
| GB9823341D0 (en) | Process for phosphodiesterase iv inhibitors | |
| GB9906058D0 (en) | A method for the quantitative detrmination of D N A | |
| GB9914436D0 (en) | A method | |
| GB9922470D0 (en) | A set of parts | |
| GB9901166D0 (en) | A set of parts | |
| HU9902898D0 (en) | Method for influancing thermosensibility | |
| GB9917294D0 (en) | Inhibitors | |
| GB9929341D0 (en) | Inhibitors | |
| GB9929340D0 (en) | Inhibitors | |
| GB9900413D0 (en) | Inhibitors |